We are international
Donate
• webcasts   TEXT SIZE   

'This is the most exciting ASH meeting that I've been to, and I've been a member for over 25 years.'
Morie Gertz, MD
Mayo Clinic

The IMF is pleased to provide you with a broad sampling of myeloma presentations and posters from the 2008 annual meeting of the American Society of Hematology in San Francisco, California. We hope you will find this material informative and useful.

 print    
ASH 2008 WEBCASTS
    next      view all

OVERVIEWS OF ASH
01.04.09   Dr. Anderson - ASH 2008 - An Overview of the 50th ASH Annual Meeting and Exposition
December 6-9, 2008
San Francisco, CA
Kenneth C. Anderson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
U.S.A.
Member, IMF Board of Scientific Advisors

01.04.09   Dr. Gertz - ASH 2008 - An Overview of the 50th ASH Annual Meeting and Exposition
December 6-9, 2008 in San Francisco, CA and
Morie Gertz, MD
Mayo Clinic
Rochester, Minnesota
USA
Member, IMF Board of Scientific Advisors

01.04.09   Dr. Rajkumar - ASH 2008 - An Overview of the 50th ASH Annual Meeting and Exposition
December 6-9, 2008
San Francisco, CA
Dr. Vincent Rajkumar
Mayo Clinic
Rochester, Minnesota
USA
Member, IMF Board of Scientific Advisors

UPDATE ON BANK ON A CURE RESEARCH
01.04.09   Dr. Van Ness - ASH 2008 - Analytical Approaches for the BOAC SNP Panel Association with Progression Free Survival in Myeloma
Brian Van Ness, PhD
University of Minnesota
Institute of Human Genetics
Minneapolis, Minnesota
USA
Member, IMF Board of Scientific Advisors

GENETIC STUDIES
01.04.09   Dr. Morgan - ASH 2008 - Genetic Variation in ADME Genes Is Associated with Thalidomide Related Peripheral Neuropathy in Multiple Myeloma Patients
Gareth Morgan, MD
Section of Haemato-Oncology
The Institute of Cancer Research
London, United Kingdom
Member, IMF Board of Scientific Advisors

01.04.09   Dr. Morgan - ASH 2008 - High Resolution Genomic Profiling Using Single Nucleotide Polymorphism Microarrays Identifies Multiple Novel Genomic Minimally Deleted Regions in Multiple Myeloma
Gareth Morgan, MD
Section of Haemato-Oncology
The Institute of Cancer Research
London, United Kingdom
Member, IMF Board of Scientific Advisors

01.04.09   Dr. Munshi - ASH 2008 - Alternate Splicing Is a Frequent Event and Impacts Clinical Outcome in Myeloma: A High-Density Exon Array Analysis of Uniformly Treated Newly-Diagnosed Myeloma Patients
Nikhil Munshi, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
USA
Member, IMF Board of Scientific Advisors

01.04.09   Dr. Reece - ASH 2008 - The Impact of Cytogenetics on the Outcomes of Treatment with Lenalidomide Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma
Donna E. Reece, MD
Princess Margaret Hospital
Toronto, Ontario
Canada
Member, IMF Board of Scientific Advisors

01.04.09   Dr. Goldschmidt - ASH 2008 - Inhibition of Aurora-Kinases for Tailored Risk-Adapted Treatment of Multiple Myeloma
Hartmut Goldschmidt, MD
Universitätsklinikum Heidelberg und Nationales Centrum für Tumorerkrankungen
Heidelberg, Germany
Member, IMF Board of Scientific Advisors

01.04.09   Dr. Beksac - ASH 2008 - HLA Specificities and Predisposition to the Development of Multiple Myeloma (MM)
Meral Beksac, MD
Ankara University School of Medicine
Ankara, Turkey
Member, IMF Board of Scientific Advisors

    next      view all